6-170561958-A-G
Position:
Variant summary
Our verdict is Benign. Variant got -21 ACMG points: 0P and 21B. BP4_StrongBP6_Very_StrongBP7BA1
The NM_003194.5(TBP):āc.222A>Gā(p.Gln74=) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0642 in 142,038 control chromosomes in the GnomAD database, including 429 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (ā ā ).
Frequency
Genomes: š 0.064 ( 429 hom., cov: 26)
Exomes š: 0.033 ( 1010 hom. )
Failed GnomAD Quality Control
Consequence
TBP
NM_003194.5 synonymous
NM_003194.5 synonymous
Scores
2
Clinical Significance
Conservation
PhyloP100: 1.12
Genes affected
TBP (HGNC:11588): (TATA-box binding protein) Initiation of transcription by RNA polymerase II requires the activities of more than 70 polypeptides. The protein that coordinates these activities is transcription factor IID (TFIID), which binds to the core promoter to position the polymerase properly, serves as the scaffold for assembly of the remainder of the transcription complex, and acts as a channel for regulatory signals. TFIID is composed of the TATA-binding protein (TBP) and a group of evolutionarily conserved proteins known as TBP-associated factors or TAFs. TAFs may participate in basal transcription, serve as coactivators, function in promoter recognition or modify general transcription factors (GTFs) to facilitate complex assembly and transcription initiation. This gene encodes TBP, the TATA-binding protein. A distinctive feature of TBP is a long string of glutamines in the N-terminus. This region of the protein modulates the DNA binding activity of the C terminus, and modulation of DNA binding affects the rate of transcription complex formation and initiation of transcription. The number of CAG repeats encoding the polyglutamine tract is usually 25-42, and expansion of the number of repeats to 45-66 increases the length of the polyglutamine string and is associated with spinocerebellar ataxia 17, a neurodegenerative disorder classified as a polyglutamine disease. Two transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Jul 2016]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -21 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.67).
BP6
Variant 6-170561958-A-G is Benign according to our data. Variant chr6-170561958-A-G is described in ClinVar as [Likely_benign]. Clinvar id is 2590300.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr6-170561958-A-G is described in Lovd as [Likely_benign].
BP7
Synonymous conserved (PhyloP=1.12 with no splicing effect.
BA1
GnomAd4 highest subpopulation (NFE) allele frequency at 95% confidence interval = 0.101 is higher than 0.05.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
TBP | NM_003194.5 | c.222A>G | p.Gln74= | synonymous_variant | 3/8 | ENST00000392092.7 | NP_003185.1 | |
TBP | NM_001172085.2 | c.162A>G | p.Gln54= | synonymous_variant | 2/7 | NP_001165556.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
TBP | ENST00000392092.7 | c.222A>G | p.Gln74= | synonymous_variant | 3/8 | 1 | NM_003194.5 | ENSP00000375942 | P2 |
Frequencies
GnomAD3 genomes AF: 0.0643 AC: 9120AN: 141932Hom.: 430 Cov.: 26
GnomAD3 genomes
AF:
AC:
9120
AN:
141932
Hom.:
Cov.:
26
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.0238 AC: 3563AN: 149640Hom.: 46 AF XY: 0.0230 AC XY: 1874AN XY: 81604
GnomAD3 exomes
AF:
AC:
3563
AN:
149640
Hom.:
AF XY:
AC XY:
1874
AN XY:
81604
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome Data not reliable, filtered out with message: AS_VQSR AF: 0.0328 AC: 40977AN: 1249038Hom.: 1010 Cov.: 103 AF XY: 0.0337 AC XY: 21026AN XY: 624590
GnomAD4 exome
Data not reliable, filtered out with message: AS_VQSR
AF:
AC:
40977
AN:
1249038
Hom.:
Cov.:
103
AF XY:
AC XY:
21026
AN XY:
624590
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.0642 AC: 9116AN: 142038Hom.: 429 Cov.: 26 AF XY: 0.0611 AC XY: 4241AN XY: 69420
GnomAD4 genome
AF:
AC:
9116
AN:
142038
Hom.:
Cov.:
26
AF XY:
AC XY:
4241
AN XY:
69420
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
ClinVar
Significance: Likely benign
Submissions summary: Benign:2
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
Inborn genetic diseases Benign:1
Likely benign, criteria provided, single submitter | clinical testing | Ambry Genetics | Aug 02, 2023 | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. - |
not provided Benign:1
Likely benign, criteria provided, single submitter | not provided | Breakthrough Genomics, Breakthrough Genomics | - | - - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
CADD
Benign
DANN
Benign
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at